Novoprotein Scientific Inc. (SHA:688137)

China flag China · Delayed Price · Currency is CNY
41.05
-1.14 (-2.70%)
At close: Mar 9, 2026
15.54%
Market Cap 2.86B
Revenue (ttm) 151.51M
Net Income (ttm) -76.18M
Shares Out 69.77M
EPS (ttm) -1.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 815,072
Average Volume 695,902
Open 41.15
Previous Close 42.19
Day's Range 40.22 - 41.75
52-Week Range 28.67 - 54.56
Beta 1.81
RSI 40.72
Earnings Date Apr 29, 2026

About Novoprotein Scientific

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular research and diagnosis, and virus-related products, including antigens, antibodies and test kits. The company also provides protein expression and puri... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 556
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688137
Full Company Profile

Financial Performance

In 2025, Novoprotein Scientific's revenue was 151.51 million, an increase of 18.78% compared to the previous year's 127.56 million. Losses were -76.18 million, 40.0% more than in 2024.

Financial Statements

News

There is no news available yet.